Table.

The baseline parameters and clinical efficacy of the two groups (n = 95).

Groups	MMI		MMI + Se		F/c2	P
	Before	After	Before	After
Sex
Male	19		14		0.393	0.531
Female	31		30
Age	40.20 ± 12.63		38.89 ± 11.59		0.252	0.602
FT3	28.42 ± 14.76	13.39 ± 7.41*	27.93 ± 10.82	5.29 ± 1.02**	12.727	0.003
FT4	66.14 ± 26.52	16.59 ± 3.34**	70.97 ± 29.12	9.29 ± 4.27**	7.897	0.037
TSH	0.006 ± 0.001	2.11 ± 0.32**	0.004 ± 0.002	2.30 ± 0.54**	3.099	0.773
A-TG	772.69 ± 166.16	440.99 ± 104.27*	778.42 ± 199.90	366.37 ± 78.88*	57.752	<0.001
A-TPO	353.21 ± 36.71	128.28 ± 36.95	321.36 ± 30.02	95.22 ± 23.68*	0.848	<0.001
TRAb	21.01 ± 11.69	5.27 ± 3.46**	20.09 ± 12.51	3.33 ± 1.43*	3.953	0.004

Data are represented as mean ± SD. *P < 0.05 and **P < 0.001 versus patients before treatment.